With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to help physicians save time, so they can provide better care for their patients." Fiscal 2025 Second Quarter Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2023. Revenue:

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and Anna Bryson, chief financial officer, will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 11:30 a.m. GMT/6:30 a.m. ET. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date w

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members includ

With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. "We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines," said Jeff Tangney, co-founder and CEO of Doximity. "Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients." Fiscal 2025 First Quarter Financial Highlights All compa

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include mor

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5, 2024 at 2:00 p.m. Central Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their

Report shows 5.9% increase in average physician compensation, 23% gender wage gap, and 86% of physicians concerned about care for aging population Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released its 2024 Physician Compensation Report. The report reveals that the average pay for doctors increased 5.9% in 2023 after a decline of 2.4% the previous year. The report also points to a 23% gender wage gap, with men physicians earning nearly $102,000 more than women physicians, even when controlling for specialty, location, and years of experience. The report also includes new findings related to physician career satisfaction, including the

Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 fourth quarter and fiscal year ended March 31, 2024. "We were pleased to beat on our top and bottom lines, as we delivered another quarter of strong profits and record engagement," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to bring AI and a

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe

Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to help physicians save time, so they can provide better care for their patients." Fiscal 2025 Second Quarter Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2023. Revenue:

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members includ

Total revenues of $126.7 million, up 17% year-over-year Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. "We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines," said Jeff Tangney, co-founder and CEO of Doximity. "Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients." Fiscal 2025 First Quarter Financial Highlights All compa

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include mor

Fiscal year 2024 total revenues of $475.4 million, up 13% year-over-year Fiscal year 2024 net income growth of 31% and adjusted EBITDA growth of 25% year-over-year Q4 total revenues of $118.1 million, up 6% year-over-year Q4 net income growth of 32% and adjusted EBITDA growth of 15% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 fourth quarter and fiscal year ended March 31, 2024. "We were pleased to beat on our top and bottom lines, as we delivered another quarter of strong profits and record engagement," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to bring AI and a

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market close on May 16, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe

Total revenues of $135.3 million, up 17% year-over-year Net income margin of 35% and adjusted EBITDA margin of 54% Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 third quarter ended December 31, 2023. "We're proud to deliver another quarter of double-digit engagement growth across our entire platform, with a beat and raise on both our top and bottom lines," said Jeff Tangney, co-founder and CEO of Doximity. "Our clinical workflow tools continue to drive daily use among doctors, and we now count 17 of the top 22 U.S. hospitals as e

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2023 after market close on February 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

Total revenues of $113.6 million, up 11% year-over-year Net income margin of 27% and adjusted EBITDA margin of 48% Net income growth of 16% and adjusted EBITDA growth of 18% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023. "We're proud to make medicine mobile, with another quarter of record engagement across our entire platform," said Jeff Tangney, co-founder and CEO of Doximity. "Over 550,000 unique providers used our generative AI, telehealth, messaging, and scheduling workflow tools in Q2 to provide better care for their patients." Fiscal 2024 S

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2023 after market close on November 9, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inc

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G - Doximity, Inc. (0001516513) (Subject)

SC 13G - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

SC 13G/A - Doximity, Inc. (0001516513) (Subject)

10-Q - Doximity, Inc. (0001516513) (Filer)

8-K - Doximity, Inc. (0001516513) (Filer)

SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

8-K - Doximity, Inc. (0001516513) (Filer)

10-Q - Doximity, Inc. (0001516513) (Filer)

8-K - Doximity, Inc. (0001516513) (Filer)

ARS - Doximity, Inc. (0001516513) (Filer)

DEFA14A - Doximity, Inc. (0001516513) (Filer)

DEF 14A - Doximity, Inc. (0001516513) (Filer)

S-8 - Doximity, Inc. (0001516513) (Filer)

4 analysts have expressed a variety of opinions on Doximity (NYSE:DOCS) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 2 2 0 Last 30D 0 0 0 1 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 2 1 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.5, a high estimate of $29.00, and a low estimate of $19.00. Observing a downward trend, the cur

Wells Fargo analyst Stan Berenshteyn downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underweight and lowers the price target from $27 to $19.

Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers MultiMetaVerse Holdings Limited (NASDAQ:MMV) shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. (NASDAQ:GTBP) rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Hold

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Monday. Shares of Overseas Shipholding Group, Inc. (NYSE:OSG) rose sharply during Monday's session after the company announced it entered into a definitive merger agreement to be acquired by Saltchuk Resources. The transaction is valued at an aggregate equity value of around $653 million and a total transaction value of $950 million. Overseas Shipholding Group shares climbed 22.8% to $8.43 on Monday. Here are some other big stocks recording gains in today's session. Hims & Hers Health, Inc. (NYSE:HIMS) shares jumped 30.5% to $19.01 after the company announced the addition of GLP-1 injections to it

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 50 points on Friday. The Dow traded up 0.12% to 39,917.54 while the NASDAQ fell 0.33% to 16,642.74. The S&P 500 also fell, dropping, 0.10% to 5,291.68.      . Check This Out: Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday Leading and Lagging SectorsEnergy shares rose by 1.4% on Friday. In trading on Friday, information technology shares fell by 0.8%. Top Headline U.S. leading index fell 0.6% month-over-month for April, versus market expectations for a 0.3% decline. Equities Trading UP                        Autolus Therapeutics plc (NASDAQ:AUTL) shar

Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) fell sharply during Friday's session after the company reduced its dividend and said it expects third-quarter and fourth-quarter results below its prior expectations. Cracker Barrel Old Country Store shares dipped 14.4% to $49.01 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Fangdd Network Group Ltd. (NASDAQ:DUO) shares jumped 258.6% to $1.4709. FangDD filed 2023 annual report on Form 20-F. Akanda Corp. (NASDAQ:AKAN) jumped 129.4% to $0.3053 after jumping around 27% on Thursday. Crown ElectroKinetics Corp (NASDAQ:CRKN) shares jumped 89.6% to $0.4580. The stock has seen interes

Gainers Akanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66% to $0.18. The company's market cap stands at $6.7 million. Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 29.77% to $8.63. The company's market cap stands at $8.9 million. As per the news, the Q1 earnings report came out 3 days ago. TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 27.23% to $1.13. The market value of their outstanding shares is at $6.8 million. Onconetix (NASDAQ:ONCO) stock increased by 26.73% to $0.18. The market value of their outstanding shares is at

U.S. stocks traded mixed midway through trading, with the NASDAQ Composite edging lower on Friday. The Dow traded up 0.07% to 39,896.89 while the NASDAQ fell 0.02% to 16,695.66. The S&P 500 also rose, gaining, 0.01% to 5,297.40.      . Check This Out: Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday Leading and Lagging SectorsEnergy shares rose by 0.6% on Friday. In trading on Friday, health care shares fell by 0.3%. Top Headline RBC Bearings Incorporated (NYSE:RBC) shares gained around 4% on Friday after it reported fourth-quarter FY24 results. Net sales rose 4.9% Y/Y to $413.7 million, beating the consensus of $413.5 million. Adjusted EPS incre

U.S. stocks were mixed, with the Dow Jones gaining around 0.1% on Friday. Shares of Despegar.com, Corp. (NYSE:DESP) rose sharply during Friday's session after the company reported better-than-expected quarterly sales results. Despegar.com posted GAAP earnings of 7 cents per share, versus market estimates of 15 cents per share. The company's quarterly sales came in at $173.700 million beating expectations of $171.556 million, according to data from Benzinga Pro. Despegar.com shares jumped 19.7% to $15.01 on Friday. Here are some other big stocks recording gains in today's session. Doximity, Inc. (NYSE:DOCS) gained 19.7% to $28.41 reported stronger-than-expected financial resul